SB-Glim 4 mg (Tablet)
Unit Price: ৳ 15.00 (50's pack: ৳ 750.00)
Medicine Details
| Category | Details |
|---|---|
| Generic | Glimepiride |
| Company | Sunman birdem pharma ltd |
| Also available as |
Indications
- Adjunct to diet and exercise to lower blood glucose in noninsulin-dependent diabetes mellitus (NIDDM)
- Use in combination with metformin or insulin for adequate glycaemic control
Pharmacology
Stimulates insulin release from pancreatic beta cells, reduces hepatic glucose production, improves peripheral tissue sensitivity to insulin
Dosage
- Initial Dose: 1 mg once daily
- Usual Dose Range: 1 to 4 mg daily
- Timing and Distribution: Decided by physician based on patient's lifestyle
- Secondary Dosage Adjustment: Considered as control of diabetes improves
- Changeover from Other Oral Antidiabetics: Initial dose of 1 mg
Administration
Tablets must be swallowed with sufficient liquid
Interaction
- Potentiate the Hypoglycaemic Action:
- ACE inhibitors
- Cyclophosphamide
- Fluconazole
- Attenuate the Hypoglycaemic Action:
- Acetazolamide
- Barbiturates
- Calcium channel blockers
Contraindications
- Insulin dependent diabetes mellitus
- Diabetic ketoacidosis
- Hypersensitivity to Glimepiride or sulfonylureas
- Severe hepatic dysfunction
- Severe impairment of renal function
Side Effects
- Hypoglycaemia
- Nausea
- Temporary visual impairment
- Abdominal pain
Pregnancy & Lactation
Not suitable for use during pregnancy or breastfeeding
Precautions & Warnings
Increased risk of hypoglycaemia in initial weeks of treatment, necessitates careful monitoring
Overdose Effects
Can produce hypoglycaemia, requiring aggressive treatment with glucose and close monitoring
Therapeutic Class
Sulfonylureas
Storage Conditions
Store below 30°C, away from light and out of reach of children